It's full steam ahead for a new Regeneron facility in Saratoga Springs. The company has learned that Saratoga County's ...

Pharma marketers are still getting up to speed on the changing health data privacy landscape. Here’s how they can develop ...

Here’s a closer look at the top pharmaceutical companies that have earned favorable rankings from Wolfe Research analysts. Johnson & Johnson takes the top spot with growth primarily driven by new ...

LIB Therapeutics has scored an FDA approval for its cholesterol-lowering, third-generation PCSK9 inhibitor, lerodalcibep-liga ...

Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced that Jake Becraft, PhD, Co-founder ...

Biocon Biologics inks settlement and license agreement to commercialize biosimilar aflibercept worldwide: Our Bureau, Bengaluru Monday, December 15, 2025, 16:45 Hrs [IST] Biocon B ...

It marks the first country in the EU where the company would be directly launching Liraglutide under its own brand.

Could a new class of oral drugs be game changers?

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along ...

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is initiating a Phase 2 study ...

The request comes amid continuing uncertainty over federal funding, with research and thousands of jobs on the line.

Several headwinds have pushed Regeneron 's (NASDAQ: REGN) shares lower over the past year and a half. However, the company is bouncing back and has performed well in recent months. What's more, there ...